# Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)

> **NCT07518914** · NA · NOT_YET_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 1500 (estimated)

## Conditions studied

- Misinformation
- Lenacapavir

## Interventions

- **BEHAVIORAL:** Diabetes information
- **BEHAVIORAL:** Enhanced inoculation message

## Key facts

- **NCT ID:** NCT07518914
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-04
- **Final completion:** 2029-04
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07518914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07518914, "Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07518914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*